SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile shares saw a sharp pullback after reporting first-quarter earnings that missed revenue and profit expectations, with community sentiment splitting between investors who believe long-term potential outweighs short-term execution hurdles and bears highlighting concerns over cash burn and launch delays. While the community is actively debating the company's ability to reach its year-end satellite deployment targets, bulls remain focused on reaffirmed guidance, new government contract awards, and the massive runway provided by current cash reserves.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is facing intense volatility following a mixed earnings report, where a bottom-line miss triggered a sharp sell-off while management's raised full-year guidance and expansion into peptide manufacturing provided a counter-narrative. The community remains deeply divided, with bulls pointing to long-term growth and platform scalability, while bears highlight margin pressure and intense competition as significant risks to the stock's future.

BOTCOIN is an experiment in giving AI agents the ability to earn (mine) currency via work that is only solvable at scale by an LLM; solving complex natural language tasks that require reasoning. Right now the challenges generated are arbitrary and designed to scale infinitely, however you could envision a future in which humans or agents submit work for LLMs by depositing BOTCOIN into epoch rewards, send out the research requirements, and criteria are designed and committed on chain that would characterize an eligible "solve."  BOTCOIN is an epoch-based reward system for proof-of-inference work. All miner rewards are settled on-chain. Supply is fixed at 100,000,000,000 and was launched fairly via BANKR.

BOTCOIN

BOTCOIN is experiencing a surge in social sentiment driven by the broader momentum in the AI-focused cryptocurrency sector. Investors are actively discussing the token's technical breakout potential and its positioning alongside other trending artificial intelligence projects.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is experiencing a surge in trading volume and bullish sentiment following the live deployment of its Dirac-3 optimization machine on the Quantum Corridor network. Investors are actively discussing the stock's potential for a significant short squeeze and its long-term strategic shift toward commercializing photonic and edge-AI hardware, such as the NeuraWave platform, as a differentiator against larger quantum competitors.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending due to a massive rebound following recent volatility, fueled by aggressive retail accumulation, speculation regarding potential new high-profile partnerships, and anticipation ahead of upcoming earnings. Community sentiment remains deeply divided, with bulls pointing to the company's photonics interposer technology as a critical AI infrastructure play, while skeptics emphasize persistent financial losses, management credibility concerns, and the risks associated with shareholder dilution.

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

Plus Therapeutics Inc

Plus Therapeutics is facing intense community debate as the stock experiences extreme volatility and downward pressure despite recent news regarding FDA orphan drug designation and new billing code approvals. While some investors remain bullish, pointing to a low float and potential for a short squeeze, many others are expressing frustration over historical patterns of dilution, reverse splits, and stagnant price performance.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending as investors react to strong earnings and a massive project backlog, further fueled by speculation regarding high-profile AI data center partnerships and hyperscaler demand. Community discussion remains focused on the company's ability to capitalize on immediate off-grid power needs, with many highlighting recent contract momentum as a long-term catalyst despite previous volatility from short-seller reports.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is trending as investors closely watch upcoming earnings and potential milestones for the Helios data center, which is positioning the company as a key AI infrastructure and data center player. Community sentiment remains focused on the impact of potential hyperscaler partnerships, the Clarity Act, and the broader institutional shift toward tokenization.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token is generating significant community excitement and high watch activity, driven by a strong AI narrative and a recent reduction in token emissions that has sparked interest in its deflationary potential. Traders are actively debating whether the current price levels represent a healthy consolidation for a major AI competitor or a temporary fluctuation before a broader bull market push.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is attracting significant attention as investors await the upcoming Phase 3 VELA-1 and VELA-2 dataset, which is viewed as a crucial catalyst to validate sonelokimab as a best-in-class treatment for inflammatory skin diseases. Community sentiment remains focused on the potential for institutional accumulation and long-term value, despite ongoing volatility and concerns regarding short interest and the timing of clinical trial readouts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$URGO 71.79% 
$BIAF 70.14% 
$PTLE 68.63% 
$ASNS 43.81% 
$JZ 43.70%